Both companies have contracts to provide vaccine to the United States and other governments if they are cleared by regulators. FDA reviewed all safety data from trials globallyInfections are rising in 80 countries as people in the northern hemisphere spend more time indoors with winter approaching. J&J is also in discussions with other regulators to resume a trial outside of the United States, the company said. AstraZeneca said that the FDA has reviewed all safety data from the trials globally and deemed it safe to continue testing the vaccine. AstraZeneca trials in the U.K., Brazil and South Africa resumed last month even as the FDA continued its investigation into the case.

Source: CBC News October 23, 2020 23:03 UTC